Beijing Biostar Pharmaceuticals Co., Ltd. announced that its auditors may issue a qualified opinion on the forthcoming annual results because of uncertainties surrounding the recoverability of an investment fund.
The company is currently engaging with the auditors to resolve the matter and stated that additional information will be provided in the full-year results announcement.
The board advised shareholders and potential investors to exercise caution when dealing in the company’s shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments